Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar;184(1):116-123.
doi: 10.1002/ajmg.c.31764. Epub 2020 Jan 8.

Investigation of de novo variation in pediatric cardiomyopathy

Ashley Parrott  1 , Philip R Khoury  1 , Amy R Shikany  1 , Angela Lorts  1 , Chet R Villa  1 , Erin M Miller  1
Affiliations

Investigation of de novo variation in pediatric cardiomyopathy

Ashley Parrott et al. Am J Med Genet C Semin Med Genet. 2020 Mar.

Abstract

Pediatric cardiomyopathies can be caused by variants in genes encoding the sarcomere and cytoskeleton in cardiomyocytes. Variants are typically inherited in an autosomal dominant manner with variable expressivity. De novo variants have been reported, however their overall frequency is largely unknown. We sought to determine the rate of de novo, pathogenic and likely pathogenic (P/LP) variants in children with a diagnosis of hypertrophic, dilated, or restrictive cardiomyopathy (HCM, DCM, or RCM), and to compare disease outcomes between individuals with and without a de novo variant. A retrospective record review identified 126 individuals with HCM (55%), DCM (37%), or RCM (8%) ≤18 years of age who had genetic testing. Overall, 50 (40%) had positive genetic testing and 18% of P/LP variants occurred de novo. The rate of de novo variation in those with RCM (80%) was higher than in those with HCM (9%) or DCM (20%). There was evidence of germline mosaicism in one family with RCM. Individuals with de novo variants were more likely than those without to have a history of arrhythmia (p = .049), sudden cardiac arrest (p = .024), hospitalization (p = .041), and cardiac transplantation (p = .030). The likelihood of de novo variation and impact on family risk and screening should be integrated into genetic counseling.

Keywords: cardiomyopathy; de novo; mosaicism; pediatric.

PubMed Disclaimer

References

REFERENCES

    1. Alfares, A. A., Kelly, M. A., McDermott, G., Funke, B. H., Lebo, M. S., Baxter, S. B., … Rehm, H. L. (2015). Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: Expanded panels offer limited additional sensitivity. Genetics in Medicine, 17(11), 880-888. https://doi.org/10.1038/gim.2014.205
    1. Anderson, H. N., Cetta, F., Driscoll, D. J., Olson, T. M., Ackerman, M. J., & Johnson, J. N. (2018). Idiopathic restrictive cardiomyopathy in children and young adults. The American Journal of Cardiology, 121(10), 1266-1270. https://doi.org/10.1016/j.amjcard.2018.01.045
    1. Bonaventure, J., Rousseau, F., Legeai-Mallet, L., Le Merrer, M., Munnich, A., & Maroteaux, P. (1996). Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism. American Journal of Medical Genetics, 63(1), 148-154. https://doi.org/10.1002/(SICI)1096-8628(19960503)63:1<148::AID-AJMG26...
    1. Forissier, J. F., Richard, P., Briault, S., Ledeuil, C., Dubourg, O., Charbonnier, B., … Hainque, B. (2000). First description of germline mosaicism in familial hypertrophic cardiomyopathy. Journal of Medical Genetics, 37(2), 132-134. https://doi.org/10.1136/jmg.37.2.132
    1. Francioli, L. C., Polak, P. P., Koren, A., Menelaou, A., Chun, S., Renkens, I., … Sunyaev, S. R. (2015). Genome-wide patterns and properties of de novo mutations in humans. Nature Genetics, 47(7), 822-826. https://doi.org/10.1038/ng.3292

Publication types

MeSH terms